Search results
Your search for Orgran returned no results
Showing 31 to 45 of 302 results for organ
Showing 31 to 45 of 302 results for organ
This quality standard covers diagnosing and managing hypertension (high blood pressure) and pre-eclampsia during pregnancy, labour and birth. It also covers advice for women with hypertension who may become pregnant and postnatal care for women who have had hypertension or pre-eclampsia. It describes high-quality care in priority areas for improvement.
View quality statements for QS35Show all sections
Sections for QS35
- Quality statements
- Quality statement 1: Pre-pregnancy advice for women with treated hypertension
- Quality statement 2: Antenatal assessment of pre-eclampsia risk
- Quality statement 3: Antenatal blood pressure targets
- Quality statement 4: Assessing women with severe hypertension in pregnancy
- Quality statement 5: Admission to hospital for women with pre-eclampsia
- Quality statement 6: Timing of birth for women with pre-eclampsia
- Quality statement 7: Transfer of information about ongoing management
Machine perfusion systems and cold static storage of kidneys from deceased donors (TA165)
Evidence-based recommendations on machine perfusion systems and cold static storage of kidneys from deceased donors.
Immunosuppressive therapy for kidney transplant in children and young people (TA482)
Evidence-based recommendations on immunosuppressive therapies for preventing kidney rejection in children and young people. The therapies are basiliximab (Simulect), immediate-release tacrolimus (Adoport, Capexion, Modigraf, Prograf, Tacni, Vivadex), mycophenolate mofetil (Cellcept and non-branded versions), rabbit anti-human thymocyte immunoglobulin (Thymoglobuline), prolonged-release tacrolimus (Advagraf, Envarsus), mycophenolate sodium (Myfortic, Ceptava), sirolimus (Rapamune), everolimus (Certican) and belatacept (Nulojix).
Reasons for refusal for consent:- Why do families refuse to give permission for organ donation?
for refusal for consent:- Why do families refuse to give permission for organ donation? Any explanatory notes(if applicable) Why this is...
Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse
cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse Any explanatory notes(if applicable) Source...
effectiveness of colpocleisis compared with sacrospinous fixation for pelvic organ prolapse in elderly women? Any explanatory notes(if...
This guideline covers care and support for people with advanced (stage 4) breast cancer. It aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life.
This guideline covers integrated diagnostic reporting for diagnosing haematological cancer in adults, young people and children. It also covers staffing, facilities (levels of care) and multidisciplinary teams needed for adults and young people. It aims to improve care for people with suspected or diagnosed cancer by promoting best practice on the organisation of haematological cancer services.
View recommendations for NG47Show all sections
Recommendation ID CG135/5 Question The experience of consenting for organ donation:- Does a positive experience of approach and process...
Summary of the evidence on infliximab for treating refractory extrapulmonary sarcoidosis to inform local NHS planning and decision-making
urinary incontinence or pelvic organ prolapse Treating complications from mesh used for stress urinary incontinence or pelvic...
Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)
Evidence-based recommendations on eculizumab (Soliris) for treating atypical haemolytic uraemic syndrome in adults and children.
satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women? Any explanatory notes(if applicable)
surgical management for women with both stress urinary incontinence and pelvic organ prolapse, including the sequence of interventions?...
compared with non-mesh surgery for stress urinary incontinence and pelvic organ prolapse in women? Any explanatory notes(if applicable)